Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New toothpaste fights plaque in quick study

NCT ID NCT07419737

Disease control Sponsor: Church & Dwight Company, Inc. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a toothpaste with stannous fluoride can prevent dental plaque better than a regular fluoride toothpaste. 91 healthy adults brushed twice daily for 14 days after a professional teeth cleaning. Plaque levels were measured at the start, after one day, and after two weeks.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

91 people

The number who actually took part.

Started

Oct 2024

Finished

Dec 2024

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 69 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Good general health based on medical history * Minimum of 18 natural teeth with scorable surfaces * Baseline mean plaque score ≥2.0 * Willing to refrain from non-study oral hygiene products * Willing to abstain from oral hygiene prior to study visits * Able and willing to comply with study procedures Exclusion Criteria: * Known allergy to oral care products * Conditions limiting normal brushing * Significant medical conditions affecting study participation * Pregnant or nursing females * Severe periodontal disease * Recent dental prophylaxis * Recent participation in another dental study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Dental plaque are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Dental Plaque

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Dental plaque

Contacts and locations

Locations

  • Salus Research, Inc.

    Fort Wayne, Indiana, 46825, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.